368 related articles for article (PubMed ID: 14668180)
1. Results from clinical trials on ST-elevation myocardial infarction in a historic perspective with some pathophysiological aspects.
Otterstad JE; Brosstad F
Scand Cardiovasc J; 2003 Dec; 37(6):316-23. PubMed ID: 14668180
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
Gibson CM; Murphy SA; Montalescot G; Morrow DA; Ardissino D; Cohen M; Gulba DC; Kracoff OH; Lewis BS; Roguin N; Antman EM; Braunwald E;
J Am Coll Cardiol; 2007 Jun; 49(23):2238-46. PubMed ID: 17560287
[TBL] [Abstract][Full Text] [Related]
3. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
[TBL] [Abstract][Full Text] [Related]
4. Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI).
Morrison DA; Berman M; El-Amin O; McLaughlin RT; Bates ER
Minerva Cardioangiol; 2007 Oct; 55(5):593-623. PubMed ID: 17912165
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy-facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized clinical trials.
Sinno MC; Khanal S; Al-Mallah MH; Arida M; Weaver WD
Am Heart J; 2007 Apr; 153(4):579-86. PubMed ID: 17383297
[TBL] [Abstract][Full Text] [Related]
6. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
[TBL] [Abstract][Full Text] [Related]
7. Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction.
Kandzari DE
Rev Cardiovasc Med; 2006; 7 Suppl 4():S29-37. PubMed ID: 17224888
[TBL] [Abstract][Full Text] [Related]
8. Short- and long-term mortality in patients with ST-elevation myocardial infarction treated with different therapeutic strategies. Results from WIelkopolska REgional 2002 Registry (WIRE Registry).
Grajek S; Lesiak M; Araszkiewicz A; Pyda M; Skorupski W; Grygier M; Mitkowski P; Prech M; Baszko A; Janus M; Breborowicz P; Rzeźniczak J; Tarchalski J; Główka A; Cieśliński A
Kardiol Pol; 2008 Feb; 66(2):154-63; discussion 164-5. PubMed ID: 18344153
[TBL] [Abstract][Full Text] [Related]
9. Facilitated PCI: rationale, current evidence, open questions, and future directions.
Zimarino M; Sacchetta D; Renda G; De Caterina R
J Cardiovasc Pharmacol; 2008 Jan; 51(1):3-10. PubMed ID: 18209562
[TBL] [Abstract][Full Text] [Related]
10. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
Gibson CM; Murphy SA; Pride YB; Kirtane AJ; Aroesty JM; Stein EB; Ciaglo LN; Southard MC; Sabatine MS; Cannon CP; Braunwald E;
Am Heart J; 2008 Jan; 155(1):133-9. PubMed ID: 18082504
[TBL] [Abstract][Full Text] [Related]
11. Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.
Eikelboom JW; Quinlan DJ; Mehta SR; Turpie AG; Menown IB; Yusuf S
Circulation; 2005 Dec; 112(25):3855-67. PubMed ID: 16344381
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction.
Mehta RH; Sadiq I; Goldberg RJ; Gore JM; Avezum A; Spencer F; Kline-Rogers E; Allegrone J; Pieper K; Fox KA; Eagle KA;
Am Heart J; 2004 Feb; 147(2):253-9. PubMed ID: 14760322
[TBL] [Abstract][Full Text] [Related]
13. An early invasive strategy versus ischemia-guided management after fibrinolytic therapy for ST-segment elevation myocardial infarction: a meta-analysis of contemporary randomized controlled trials.
Wijeysundera HC; You JJ; Nallamothu BK; Krumholz HM; Cantor WJ; Ko DT
Am Heart J; 2008 Sep; 156(3):564-572, 572.e1-2. PubMed ID: 18760142
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute ST-segment elevation myocardial infarction in West Pomerania province of Poland. Comparison between primary coronary intervention and thrombolytic therapy.
Dryja T; Kornacewicz-Jach Z; Goracy J; Przybycień K; Jodko L; Skowronek A; Kurowski M; Zinka E
Kardiol Pol; 2006 Jun; 64(6):591-9; discussion 600-1. PubMed ID: 16810577
[TBL] [Abstract][Full Text] [Related]
15. Thrombolysis followed by early revascularization: an effective reperfusion strategy in real world patients with ST-elevation myocardial infarction.
Jaffe R; Halon DA; Karkabi B; Goldstein J; Rubinshtein R; Flugelman MY; Lewis BS
Cardiology; 2007; 107(4):329-36. PubMed ID: 17268198
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
Ferguson JJ; Wilson JM; Diez J
Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
[TBL] [Abstract][Full Text] [Related]
17. [Antithrombotic therapy in the treatment of STEMI and NSTEMI patients].
Nikolić Heitzler V; Pavlov M; Babić Z; Bulj N
Acta Med Croatica; 2009 Feb; 63(1):117-9. PubMed ID: 19681476
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials.
De Luca G; Marino P
Am Heart J; 2007 Dec; 154(6):1085.e1-6. PubMed ID: 18035079
[TBL] [Abstract][Full Text] [Related]
19. Evolving management of ST-segment elevation myocardial infarction: update on recent data.
Cannon CP
Am J Cardiol; 2006 Dec; 98(12A):10Q-21Q. PubMed ID: 17169625
[TBL] [Abstract][Full Text] [Related]
20. A percutaneous coronary intervention-thrombolytic predictive instrument to assist choosing between immediate thrombolytic therapy versus delayed primary percutaneous coronary intervention for acute myocardial infarction.
Kent DM; Ruthazer R; Griffith JL; Beshansky JR; Concannon TW; Aversano T; Grines CL; Zalenski RJ; Selker HP
Am J Cardiol; 2008 Mar; 101(6):790-5. PubMed ID: 18328842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
